US Healthcare and Pharma Digital Ad Spending 2022

Adjusting to the New Normal in Digital Engagement

About This Report
The pandemic is becoming endemic, and the changes consumers adapted to in the past two years—such as telehealth and retail health clinics—are here to stay. Healthcare and pharmaceutical advertisers must reassess their digital strategies to boost engagement with consumers and healthcare professionals.

Executive Summary

The pandemic upended everything in healthcare, even advertising. Spending on digital channels surged in 2020 and again in 2021. Now, marketers are grappling with a new landscape where consumers access treatment through video visits, mobile apps, and text messages.

But what’s top of mind for healthcare and pharmaceutical marketers wasn’t caused by the pandemic—it’s the impending deprecation of third-party cookies, even after Google postponed its rollout until late 2024. Advertisers are exploring tools like first-party data and contextual targeting to stay connected to consumers and clinicians alike.

Key Question: What’s driving healthcare and pharma digital ad spending growth today?

KEY STAT: Digital ad spending in the industry will reach $15.84 billion in 2022. Although growth in digital budgets is slowing, we estimate the category will see nearly $20 billion in spending in 2024.

Access All Charts and Data

Gain access to reliable data presented in clear and intelligible displays for quick understanding and decision making on the most important topics related to your industry, included at no extra cost.


Lisa Phillips


Ethan Cramer-Flood
Senior Forecasting Writer
Zach Goldner
Junior Forecasting Analyst
Jeane Han
Senior Researcher
Rajiv Leventhal
Analyst, Digital Health
Evelyn Mitchell
Analyst, Digital Advertising & Media
Oscar Orozco
Director, Forecasting
Melissa Rosenberg
Senior Researcher

"Behind the Numbers" Podcast